OraSure Technologies Inc manufactures oral fluid diagnostic products and specimen-collection devices, as well as diagnostic products used on other specimen types and medical devices used to remove benign skin lesions. The firm operates in two segments: OSUR and DNAG. The OSUR business contributes the majority of revenue and sells diagnostic products, specimen collection devices, and medical devices. This segment also receives revenue from the sale of over-the-counter products to retail pharmacies and mass merchandisers. The DNAG business sells oral fluid collection devices used to collect samples of genetic material for molecular testing. OraSure generates the majority of its revenue in the United States.